Literature DB >> 22476705

[Visualization of radiation effects on the central nervous system].

M Essig1, J Dinkel, C Zamecnik.   

Abstract

Therapy-related side effects, which are detectable with magnetic resonance imaging (MRI) at high sensitivity, are one of the most frequent causes of morbidity in cancer patients. They can be observed in the treatment of central nervous system (CNS) diseases as well as in systemic therapy, including whole brain irradiation and chemotherapy and are more often seen due to the better overall survival. This review describes the most frequent acute and chronic therapy-related changes in the CNS and the imaging findings. Acute changes are often reversible while chronic changes can be observed up to several years after treatment.The differentiation of treatment-related from tumor-related changes might be very difficult, although modern imaging modalities such as MR spectroscopy or MR perfusion measurements supply helpful differential diagnostic information.

Entities:  

Mesh:

Year:  2012        PMID: 22476705     DOI: 10.1007/s00117-011-2197-8

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  27 in total

Review 1.  Mechanisms of radiation injury to the central nervous system: implications for neuroprotection.

Authors:  C Shun Wong; Albert J Van der Kogel
Journal:  Mol Interv       Date:  2004-10

Review 2.  [Neurological complications of neurooncological therapy].

Authors:  U Herrlinger; J P Steinbach
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

3.  The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice.

Authors:  Gordon Winocur; Janette Vardy; Malcolm A Binns; Leslie Kerr; Ian Tannock
Journal:  Pharmacol Biochem Behav       Date:  2006-08-28       Impact factor: 3.533

4.  CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group.

Authors:  H Hertzberg; W J Huk; M A Ueberall; T Langer; W Meier; R Dopfer; M Skalej; H Lackner; U Bode; G Janssen; F Zintl; J D Beck
Journal:  Med Pediatr Oncol       Date:  1997-06

5.  Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.

Authors:  Igor T Gavrilovic; Adília Hormigo; Joachim Yahalom; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

Review 6.  Radiation-induced cavernous hemangiomas: case report and literature review.

Authors:  Mark Robert Keezer; Rolando Del Maestro
Journal:  Can J Neurol Sci       Date:  2009-05       Impact factor: 2.104

7.  Changes in oligodendrocytes and myelin gene expression after radiation in the rodent spinal cord.

Authors:  Shelley Atkinson; Yu-Qing Li; C Shun Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

Review 8.  Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.

Authors:  B Morris; S Partap; K Yeom; I C Gibbs; P G Fisher; A A King
Journal:  Neurology       Date:  2009-10-07       Impact factor: 9.910

Review 9.  Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide.

Authors:  Jörg Dietrich; Jörg Marienhagen; Berthold Schalke; Ulrich Bogdahn; Felix Schlachetzki
Journal:  Ann Pharmacother       Date:  2003-12-15       Impact factor: 3.154

10.  Cerebral radiation necrosis following treatment of extracranial malignancies.

Authors:  J P Glass; T L Hwang; M E Leavens; H I Libshitz
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.